Gallium-67 scintigraphy in macrophagic myofasciitis

Arthritis and Rheumatism

Volumn 43, Issue 7, 2000, Pages 1520-1526

  Cherin P ^a   Authier, F J ^b   Gherardi, R K ^b   Romero, N ^a   Laforet P ^a   Eymard, B ^a   Herson, S ^a   Caillat Vigneron, N ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; GALLIUM 67;

ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; FASCIITIS; FEMALE; FIBROMYALGIA; HUMAN; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYALGIA; MYOSITIS; POLYMYOSITIS; PRIORITY JOURNAL; SARCOIDOSIS; SCINTIGRAPHY;

ADULT; AGED; CHRONIC DISEASE; FASCIITIS; FEMALE; GALLIUM RADIOISOTOPES; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 0343517130     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200007)43:7<1520::AID-ANR16>3.0.CO;2-Q     Document Type: Article

References (26)

1. Gherardi RK, Coquet M, Chérin P, Authier F-J, Laforêt P, Belec L, et al. Macrophagic myofasciitis: an emerging entity. Lancet 1998;352:347-52.
2. Chérin P, Laforet P, Gherardi RK, and the GERMMAD. Apparition d'une nouvelle entité: la myofasciite à macrophages. Rev Rhum 1998;65:593-5.
3. Chérin P, Laforet P, Gherardi RK, Authier J-F, Coquet M, Maisonoble T, et al, and the GERMMAD. La myofasciite à macrophages: description, hypothèses étiopathogéniques. Rev Med Interne 1999;20:483-9.
4. Authier FJ, Creange A, Maisonobe T, Ranoux D, Abdelmoumni A, Lorcerie B, et al. Macrophagic myofasciitis (MMF) associated with central nervous system involvement [abstract]. Neurology 1999;52 Suppl 2:A449.
5. Naschitz JE, Boss JH, Misselevitch I, Yeshurun D, Rosner I. The fasciitis-panniculitis syndromes: clinical and pathologic features. Medicine (Baltimore) 1996;75:6-16.
6. Misbah SA, Ozols B, Franks A, Mapstone N. Whipple's disease without malabsorption: new atypical features. QJM 1997;90: 765-72.
7. Gherardi RK, Coquet M, Belec L, Chariot P, Moretto P, Figarella-Branger D, et al. Macrophagic myofasciitis: a reaction to intra-muscular injections of aluminum-containing vaccines [abstract]. J Neurol 1999;246 Suppl 1:19.
8. Ando A, Nitta K, Ando I, Sanada S, Katsuda S, Tonami N, et al. Mechanism of gallium 67 accumulation in inflammatory tissue. Eur J Nucl Med 1990;17:21-7.
9. Larson SM. The role of transferrin in gallium uptake. Int J Radiat Biol 1981;8:257-66.
10. Nejmeddine F, Raphael M, Martin A, Le Roux G, Moretti JL, Caillat-Vigneron N. Ga-67 scintigraphy in B-cell non-Hodgkin's lymphoma: correlation of Ga-67 uptake with histology and transferrin receptor expression. J Nucl Med 1999;40:40-5.
11. Nejmeddine F, Caillat-Vigneron N, Escaig F, Moretti JL, Raphael M, Galle P. Mechanism involved in gallium-67 (Ga-67) uptake by human lymphoid cell lines. Cell Mol Biol 1998;44:1215-20.
12. Weiner RE. The role of transferrin and other receptors in the mechanism of Ga-67 localization. Nucl Med Biol 1990;17:141-9.
13. Clarke D, Mitchell AW, Dick R, James GD. The radiology of sarcoidosis. Sarcoidosis 1994;11:90-9.
14. Palestro CJ. The current role of gallium imaging in infection. Semin Nucl Med 1994;24:128-41.
15. Front D, Israel A. The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients. Semin Nucl Med 1995; 25:60-71.
16. Weyand CM, Wagner AD, Björnsson J, Goronzy JJ. Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J Clin Invest 1996;98:1642-9.
17. Sulavik SB, Spencer RP, Palestro CJ, Swyer AJ, Teirstein AS, Goldsmith SJ. Specificity and sensitivity of distinctive chest radiographic and/or Ga-67 images in the noninvasive diagnosis of sarcoidosis. Chest 1993;103:403-9.
18. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
19. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-72.
20. Buchpiguel CA, Roizemblatt S, Pastor EH, Hironaka FH, Cossermelli W. Cardiac and skeletal muscle scintigraphy in dermato- and polymyositis: clinical implications. Eur J Nucl Med 1996;23:199-203.
21. Chérin P. Recognition and management of myositis. Drugs 1997; 54:39-49.
22. Alonzo-Ruiz A, Zea-Mendoza AC, Salazar-Vallinas JM, Rocamora-Ripoll A, Beltran-Guttierrez D. Toxic oil syndrome: a syndrome with features overlapping those of various forms of scleroderma. Semin Arthritis Rheum 1986;15:200-12.
23. Kaufman LD, Seidman RJ, Gruber BL. L-tryptophan-associated cosinophilic perimyositis, neuritis and fasciitis: a clinicopathologic and laboratory study of 25 patients. Medicine (Baltimore) 1990; 69:187-99.
24. Mayeno AN, Benson LM, Naylor S, Colberg-Beers M, Puchalski JT, Gleich GJ. Biotransformation of 3-(phenylamino)1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome. Chem Res Toxicol 1995;8:911-6.
25. Gherardi RK, Coquet M, Claudepierre P, Authier FJ, Lechapt-Zalcman E. Dermatomyositis with hemophagocytosis histiocytosis: a differential diagnosis of macrophagic myofasciitis [abstract]. Neurology 1999;52 Suppl 2:A450.
26. Banker BQ. Other inflammatory myopathies. In: Engel AG, Franzini-Armstrong C, editors. Myology. Vol. 2. 2nd ed. New York: McGraw-Hill; 1993. p. 1461-86.